The Ninth Vahouny Symposium on Dietary Fiber, which was held in Bethesda, Maryland from June 8--11, 2010, was attended by more than 150 participants from academia, industry, and regulatory agencies. It was the first Vahouny Symposium to have been held since the adoption of a definition for dietary fiber by the Codex Alimentarius Commission in 2009 and, as such, presented an opportunity for issues surrounding the implementation of the Codex definition to be discussed by a body of scientific and regulatory experts pre-eminent in the field. Session 10 was jointly sponsored by the ILSI North America and ILSI Europe with this objective in mind. The session took the form of a workshop facilitated by Professor Julie Miller Jones of the Department of Family, Consumer and Nutritional Sciences at St. Catherine University, St. Paul, Minnesota and Dr. Martine Champ of the Nutritional Physiology Unit of the National Institute for Agronomic Research (INRA), Nantes, France.

The goals of the session were to address critical aspects of the Codex definition of dietary fiber affecting its global implementation in a harmonized fashion and to provide a forum for experts in the field to address these impacts. This session was preceded by a session chaired by Tate & Lyle in which speakers had presented an overview of the Codex definition (Joanne Lupton, Texas A&M University, College Station), an account of the methodology available for the analysis of dietary fiber in foods and beverages (Jon DeVries, General Mills, Minneapolis, MN), an overview of European and international perspectives regarding the Codex definition (Wim Caers, Beneo-Group, Belgium), and the characterization of physiological benefits of dietary fiber (Joanne Slavin, University of Minnesota, St. Paul).

Proceedings of the session {#S0001}
==========================

A summary of the implementation issues identified in the session was provided by Joanne Lupton to start the discussion. She reviewed the Codex definition for dietary fiber as adopted by the Codex Alimentarius Commission in 2009 ([@CIT0001]), and noted that despite the adoption of the definition denoting a significant step forward for a global consensus on the nature and identity of dietary fiber, the following elements of the definition would benefit from further debate:Footnote 2 to the definition, which leaves the inclusion of undigestible carbohydrates with degrees of polymerization (DP) in the range of 3 and 9 to the discretion of national authorities.The absence of a list of beneficial physiological effects and appropriate criteria for their substantiation for the purpose of compliance with the definition.The analytical methodology by which fiber in food is to be quantified.Various aspects of these issues were the subject of discussion during the remaining part of Session 10.

The exclusion/inclusion of carbohydrates with degrees of polymerization (DP) in the range of 3 to 9 {#S20002}
---------------------------------------------------------------------------------------------------

Debate about the exclusion or inclusion of carbohydrates with DPs in the range of 3 to 9 was focused on two major areas: (1) the lack of scientific support for differences in physiological effects between those oligomers with DP 3--9 and those with a higher DP and the absence of readily applicable methods that could clearly distinguish between them; and (2) the fact that the coexistence of regulations allowing two different standards for the same definition would undermine the validity of the definition.

All those who spoke regarding the physiological aspects argued that there was no basis for distinguishing between carbohydrates with a DP ≥10 and those with DP ≤9 because there were carbohydrates both above and below this cutoff point that exhibited one or more beneficial physiological effect(s) generally associated with fiber. The view was expressed that carbohydrates exhibiting beneficial physiological effects are distributed along a continuous spectrum of chain lengths with no clear differentiation at any particular DP.

Similarly, all those who spoke about methodological aspects were of the view that a universal cutoff point at a DP of 10 and above did not reflect methodological capability. Among those who spoke, there was a view that historically the cutoff point of DP ≥10[1](#FN0001){ref-type="fn"} had gained currency in the mistaken belief that it was consistently applicable to all carbohydrates in the frame for consideration as dietary fibers through precipitation in alcohol. In practice, this is not the case and methodology provides no reliable basis for imposing a distinction between carbohydrates with or without fiber-like properties on the basis of chain length alone.

In addition, many contributors to the debate were of the view that to provide a discretionary approach at the national level to excluding or including carbohydrate fractions within the scope of the definition was undesirable. For nutrition research and assessment, the absence of a common definition creates difficulties for the comparison of fiber intakes across different geographic regions and in the interpretation of studies assessing possible beneficial physiological effects where datasets are drawn from different regions. For consumers and food manufacturers, the application of different interpretations of what constitutes dietary fiber can result in a confusing nutrition messages for consumers, demand differences in food labeling of the same food marketed in different countries, and create difficulties for food manufacturers seeking to formulate products for a global market.

Nevertheless, if there had been a necessity for compromise in order to achieve agreement on a definition, then it would have been preferable to default to a position that included carbohydrates with DPs in the range of 3 to 9 within the body of the definition, with discretion included in the footnote for those who disagreed, rather than in the opposite manner as is currently in the Codex definition. If structured in this way, the default form of the definition would have been fully inclusive, more aligned with other existing definitions, and would have more accurately reflected the majority of opinion in the scientific community.

In summary, there was a strong consensus among contributors that there is no sound scientific basis for a cutoff point at a DP ≥10. The difficulty of achieving a reconsideration of this issue within the Codex Alimentarius was acknowledged. It was suggested that the reaffirmation of the existing scientific agreement on the issue would provide better, practical support to national authorities in their implementation.

Agreement on a list of beneficial physiological effects {#S20003}
-------------------------------------------------------

Initiating the discussion of beneficial physiological effects, Joanne Lupton drew attention to the three categories of dietary fiber differentiated within the Codex definition by their source: those occurring naturally in food as consumed; those obtained from food raw material by physical, enzymatic, or chemical means; and those that are synthetic in origin. Of the three categories, the definition requires that the latter two must be shown to have a physiological benefit to health, while for those occurring naturally in food as consumed, no such beneficial effect is required to be demonstrated. At the same time, the definition provides no description of what constitutes a beneficial physiological effect so, to the extent that this remains open to interpretation, it provides no clear indication of the qualifying features of fibers falling within the last two categories.

There is a diverse list of beneficial effects in common use in academia and by institutes, agencies, and authorities worldwide. Until the 2008 session of the Codex Committee on Nutrition and Foods for Special Dietary Uses (CCNFSDU) where the current definition was recommended for adoption, the Codex definition of dietary fiber itself had been presented in conjunction with an illustrative list of relevant beneficial physiological effects and had met with a clear majority of support among participating governments and observer organizations ([@CIT0002]). The list was removed during the 2008 CCNFSDU session to simplify the definition ([@CIT0003]), but the list\'s removal potentially leads to risks of higher levels of confusion as beneficial physiological effects are now open for different interpretations at the national level.

Dr. Lupton suggested that progress might be made by attempting to characterize effects in relation to three levels of agreement on the certainty of their validation:Well-established beneficial effectsProbable beneficial effectsPossible beneficial effectsIn this way, an agreed core list of beneficial effects could be drawn up to provide a working basis for the definition but, at the same time, the list could remain open to additions as emerging science provided sufficient validation.

During a discussion, the following physiological effects received support:Reduced blood total and/or LDL cholesterol levelsAttenuation of postprandial glycemia/insulinemiaReduced blood pressureIncreased fecal bulk/laxationDecreased transit timeIncreased colonic fermentation/short chain fatty acid productionPositive modulation of colonic microfloraWeight loss/reduction in adiposityIncreased satietySupport was not unequivocal in every case. The occurrence of most of the effects was considered to be well established for fibers in general but the health impact of some effects was the subject of discussion. While in a few cases (reduced blood total cholesterol, reduced blood pressure) there were considered to be clear associations between the endpoints measured and the reduction of disease risk, in other cases (increased colonic fermentability, attenuation of postprandial glycemia/insulinemia, increased satiety) the relevance of the endpoint measured was considered by some to be indeterminate. It was also noted that there is an ongoing discussion about relevant methods and the interpretation of the magnitude of effect from the perspective of a contribution to health. Furthermore, it was pointed out that an agreement of the substantiation of the beneficial nature of any proposed effects is a case-by-case process.

The view was expressed that in considering beneficial effects in the context of a definition for dietary fiber and resultant nutrient content claims, it is important to keep in mind the consumption of fibers of all types. The total fiber content of the diet contributes several different effects simultaneously and the overall benefit, however achieved mechanistically, derives primarily from the fact that fiber is not digested in the small intestine and passes to the colon intact. The beneficial outcomes of individual fiber types in individual foods should be seen in terms of their contribution to the overall benefit achieved through their contribution to total dietary fiber intake as reflected in nutrient content claims. This is in contrast to health claims made in relation to individual components where the claim is product specific and requires substantiation on a case-by-case basis in relation to the individual food ingredient.

The distinction between these two circumstances is reflected in the nature of the claims made. In the case of fiber content claims, the primary consideration of beneficial effect is in relation to the total fiber content of the diet and the value to consumers of an awareness of the importance of maintaining an adequate intake of dietary fiber from a variety of sources. In the case of health claims, the consideration is entirely product-specific with the objective of making an on-pack claim, in a language understood by consumers for products containing the effective amount of the specific component.

Overall, there was enthusiasm for agreeing on a core list of beneficial physiological effects.

Post-session survey {#S20004}
-------------------

At the suggestion of the audience, participants were invited to express their views by survey on whether or not carbohydrates with DPs in the range of 3 to 9 should be included in the definition of dietary fiber and, if a list of beneficial physiological effects were to be compiled, to express their preferences for the effects that should be included. Participants were asked to respond to the statements of the survey presented in [Fig. 1](#F0001){ref-type="fig"}, the results are displayed in [Table 1](#T0001){ref-type="table"}.

![Survey circulated during the ILSI North America -- ILSI Europe session.](FNR-54-5750-g001){#F0001}

###### 

Seventy-five responses to the survey questionnaire were received and summarized

                                                                     Positive answer   Negative answer   No answer
  ------------------------------------------------------------------ ----------------- ----------------- ------------------------------------------
  Agree with the inclusion of DP 3--9                                86.7%             2.7%              10.6%^[a](#TF0001){ref-type="table-fn"}^
  Agree with physiological response:                                                                     
   • Reduction in blood total and/or LDL cholesterol                 98.7%             1.3%              --
   • Reduction in postprandial blood glucose and/or insulin levels   96%               2.7%              1.3%
   • Increased stool bulk and/or decreased transit time              98.7%             1.3%              --
   • Fermentability by colonic microflora                            82.7%             6.7%              10.6%
  Proposed other physiological effects                               30.7%                               69.3%

Three persons declined to answer the question DP 3--9 on grounds of insufficient information to allow a decision and five persons left the answer to the question concerning DP 3--9 blank.

Overall conclusions from the session and the survey {#S0005}
===================================================

There was overwhelming support among the participants during discussion in the session for the inclusion in the definition for dietary fiber of carbohydrate polymers with DPs in the range of 3 to 9 and of the responses to the survey, 86% were in favor of including them and 3% were opposed. For reasons unknown, 11% of respondents did not address the question. Taken together, the discussion during the session and the level of support shown by the survey indicates a convincing level of agreement among experts in the field that the science supports the inclusion of carbohydrate polymers with DPs in the range of 3 to 9 and provides a rationale for science-based decision making by national authorities in their implementation of the Codex definition.

In a discussion during the session, there was clear support for the establishment of a list of beneficial physiological effects associated with the consumption of dietary fiber. More than 80% (and, in the case of the first three, more than 95%) of respondents to the survey indicated support for the inclusion of at least the following effects in the list:Reduction in blood total and/or LDL cholesterolReduction in postprandial blood glucose and/or insulin levelsIncreased stool bulk and/or decreased transit timeFermentability by colonic microfloraAlmost a third of respondents to the survey (30%) proposed the inclusion of effects additional to these four. This response would seem to argue strongly for the adoption of an open list of beneficial effects comprising in the first instance the above four listed functions and leaving open the possibility of adding other effects to the list as and when they achieve a similar level of acceptance as a result of developing science.

These results are consistent with several previous consensus documents. An international survey of fiber experts ([@CIT0004]) found strong support for inclusion of oligosaccharides that are resistant to hydrolysis by human alimentary enzymes. Also, several recent regional expert opinions or definitions include oligosaccharides and/or a similar list of physiological effects ([@CIT0005]--[@CIT0008]).
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Prior to Codex discussion of a definition for dietary fiber, debate had centered on other cutoff points on the basis that oligomers below the cutoff DPs were soluble in 80% ethanol and those above were not. In practice, no clear cutoff point can be distinguished on the basis of solubility in 80% ethanol because solubility is also determined by the chemical nature of the constituent monosaccharides rather than the number of units alone and, therefore, the relationship between chain length and solubility in ethanol is imprecise.
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